Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer

Gastric cancer is the fifth most common type of malignancy worldwide, and the survival rate of patients with advanced-stage gastric cancer is low, even after receiving chemotherapy. Here, we validated neurotensin receptor 1 (NTSR1) as a potential therapeutic target in gastric cancer. We compared NTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Akter, Hafeza, Yoon, Jung Hwan, Yoo, Young Sook, Kang, Min-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030244/
https://www.ncbi.nlm.nih.gov/pubmed/29794962
http://dx.doi.org/10.14348/molcells.2018.0025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030244/
https://www.ncbi.nlm.nih.gov/pubmed/29794962
http://dx.doi.org/10.14348/molcells.2018.0025

Ejemplares similares